v3.26.1
Share-Based Compensation (Tables)
 6 Months Ended
Jun. 30, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of Total Share-based Compensation Expense
The following table summarizes the total share-based compensation expense included in the unaudited condensed consolidated statements of operations and comprehensive loss (in thousands):
Three Months Ended June 30,Six Months Ended June 30,
2026202520262025
Research and development expenses, net
$1,107 $1,528 $2,048 $2,526 
Selling, general and administrative expenses
3,164 2,309 5,525 4,041 
Cost of sales
324 468 588 614 
Capitalized to prepaid expenses and other non-current assets
— (12)(1)(21)
Total share-based compensation expense$4,595 $4,293 $8,160 $7,160 
Schedule of Share Option Activity
The table below summarizes Company’s share option activity during the six months ended June 30, 2026:
Number of
Options		Weighted-
Average
Exercise
Price per share		Weighted-
Average
Remaining
Contractual
Term
(Years)
Aggregate
Intrinsic
Value (1)
(in thousands)
Outstanding as of December 31, 2025
31,130,935 $4.11 7.75$1,977 
Granted7,717,785 1.54 561 
Exercised(6,754)0.41 8 
Forfeited(1,096,871)2.13 9 
Expired(345,233)5.00 — 
Outstanding as of June 30, 2026
37,399,862 $3.63 7.43$768 
Exercisable as of June 30, 2026
19,261,927 $5.23 6.00$73 
Vested and expected to vest as of June 30, 2026
37,399,862 $3.63 7.43$768 
(1) Aggregate intrinsic value is calculated as the difference between the exercise price of the underlying options and the fair value of ordinary shares for those options in the money as of June 30, 2026.
Schedule of Restricted Stock Units(“RSU”) Awards Activity
The table below summarizes Company’s restricted stock unit (“RSU”) awards activity during the three months ended June 30, 2026:
Number of
restricted
units		Weighted average
grant date
fair value
Unvested and outstanding at December 31, 2025
92,500 $1.87 
Granted4,393,554 1.59 
Vested(12,500)4.23 
Forfeited(222,250)1.62 
Unvested and outstanding at June 30, 2026
4,251,304 $1.58